Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-30

Clinical Trial Update: Xian-Lian-Jie-Du Optimization Decoction As an Adjuvant Treatment for Prevention of Recurrence of Colon Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is recruiting to evaluate Xian-Lian-Jie-Du Optimization Decoction as adjuvant therapy to prevent recurrence in colon cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xian-Lian-Jie-Du Optimization Decoction

Snippet

Sponsor: Jiangsu Famous Medical Technology Co., Ltd. | Conditions: Colon Cancer | Phase 3 | Status: RECRUITING